首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1477215

脂质体药物传递市场、副产品、技术、适应症、最终用户、地理位置

Liposome Drug Delivery Market, By Product, By Technology, By Indication, By End User, By Geography

出版日期: 2024年04月10日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格

简介目录

脂质体给药市场预计到2024年将达到54.822亿美元，预计到2031年将达到99.356亿美元，2024年至2031年的年复合成长率（CAGR）为8.9%。

报告范围		报告详情
基准年：	2023年	2024 年市场规模：	54.822 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测 2024 年至 2031 年复合年增长率：	8.90%	2031 年价值预测：	99.356 亿美元

数字。 2024 年按地区分類的脂质体药物传递市场份额 (%)

脂质体药物递送是一种有前途的标靶药物递送和释放方法。脂质体是人工製备的囊泡，由类似细胞膜的脂质双层组成，可以将疏水性和亲水性药物分别封装在其水性核心和脂质膜内。这使得脂质体能够作为奈米载体，将各种治疗剂输送到目标部位，增强其疗效和生物利用度，同时减少对健康组织的毒性。脂质体製剂的最新进展提高了药物负载能力、血液循环稳定性以及主动或被动靶向能力，使其成为抗癌药物、疫苗、基因疗法等递送的潜在候选者。

市场动态：

全球脂质体药物传递市场的推动因素包括癌症和其他慢性疾病盛行率的上升、对标靶药物传递系统的需求不断增加以及奈米医学和生物製药领域主要参与者不断增加的研发投资。然而，与药物开发和监管审批相关的高成本继续限制更广泛的市场采用。人们对个人化医疗和基于奈米技术的製剂的兴趣日益浓厚，为脂质体药物製造商提供了重大机会。製药商和脂质体技术提供者之间的策略合作正在帮助将治疗应用扩展到传染病、疼痛管理和自体免疫疾病等领域。

研究的主要特点：

该报告对全球脂质体给药市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（百万美元）和年复合成长率（CAGR%）。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数描述了全球脂质体药物输送市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球脂质体药物传输市场迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
利害关係人可以透过用于分析全球脂质体药物输送市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
介绍
市场规模和预测以及同比增长（按产品）（百万美元）
按技术分類的市场规模和预测以及同比增长（百万美元）
市场规模和预测以及同比增长（按指标）（百万美元）
市场规模和预测以及同比增长（按最终用户）（百万美元）
按国家/地区分類的市场规模和预测以及同比增长（百万美元）
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
介绍
市场规模和预测以及同比增长（按产品）（百万美元）
按技术分類的市场规模和预测以及同比增长（百万美元）
市场规模和预测以及同比增长（按指标）（百万美元）
市场规模和预测以及同比增长（按最终用户）（百万美元）
按国家/地区分類的市场规模和预测以及同比增长（百万美元）
中国
印度
日本
东协
澳洲
韩国
亚太地区其他地区
中东
介绍
市场规模和预测以及同比增长（按产品）（百万美元）
按技术分類的市场规模和预测以及同比增长（百万美元）
市场规模和预测以及同比增长（按指标）（百万美元）
市场规模和预测以及同比增长（按最终用户）（百万美元）
按国家/地区分類的市场规模和预测以及同比增长（百万美元）
海湾合作委员会
以色列
中东其他地区
非洲
介绍
市场规模和预测以及同比增长（按产品）（百万美元）
按技术分類的市场规模和预测以及同比增长（百万美元）
市场规模和预测以及同比增长（按指标）（百万美元）
市场规模和预测以及同比增长（按最终用户）（百万美元）
按国家/地区分類的市场规模和预测以及同比增长（百万美元）
北非
中非
南非

第 10 章：竞争格局

公司简介
吉利德科学公司
绿叶製药集团
易普森生物製药股份有限公司
帕西拉製药公司
阿奎塔斯治疗公司
脂质体公司
武田药品工业株式会社
台湾脂质体股份有限公司
远藤国际
爵士製药公司

第 11 章：分析师观点

命运之轮
分析师观点
连贯的机会图

第 12 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6883

The liposome drug delivery market is estimated to be valued at USD 5,482.2 Mn in 2024 and is expected to reach USD 9,935.6 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 5,482.2 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	8.90%	2031 Value Projection:	US$ 9,935.6 Mn

Figure. Liposome Drug Delivery Market Share (%), By Region 2024

Liposome drug delivery is a promising approach for targeted drug delivery and release. Liposomes are artificially prepared vesicles made up of lipid bilayers similar to cell membranes that can encapsulate both hydrophobic and hydrophilic drugs within their aqueous core and lipid membranes respectively. This enables liposomes to serve as nanocarriers for the delivery of various therapeutic agents to target sites, enhancing their efficacy and bioavailability while reducing toxicity to healthy tissues. Recent advancements in liposomal formulations have improved drug loading capacity, stability in blood circulation as well as active or passive targeting capabilities, making them potential candidates for delivery of anti-cancer drugs, vaccines, gene therapies, and others.

Market Dynamics:

The global liposome drug delivery market is driven by the rising prevalence of cancer and other chronic diseases, increasing demand for targeted drug delivery systems, and growing R&D investments from key players in the nanomedicine and biopharma sectors. However, high costs associated with drug development and regulatory approvals continue to restrain broader market adoption. Growing interest in personalized medicine and nanotechnology-based formulations present significant opportunities for liposome drugs manufacturers. Strategic collaborations between drug makers and liposome technology providers are helping expand therapeutic applications into areas such as infectious diseases, pain management, and autoimmune disorders.

Key Features of the Study:

This report provides an in-depth analysis of the global liposome drug delivery market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global liposome drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Gilead Sciences, Inc., Luye Pharma Group, Ipsen Biopharmaceuticals, Inc., Pacira Pharmaceuticals, Inc., Acuitas Therapeutics, LIPOSOMA B.V., Takeda Pharmaceutical Company Limited, Taiwan Liposome Company, Ltd., Endo International, and Jazz Pharmaceuticals plc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global liposome drug delivery market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global liposome drug delivery market

Detailed Segmentation-

Product:
- Liposomal Paclitaxel
- Liposomal Doxorubicin
- Liposomal Amphotericin B
- Others
Technology:
- Stealth Liposome Technology
- Non-PEGylated Liposome Technology
- DepoFoam Liposome Technology
Indication:
- Fungal Diseases
- Pain Management
- Cancer Therapeutics
- Others
End User:
- Hospitals
- Clinics
- Research Laboratories
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Gilead Sciences, Inc.
- Luye Pharma Group
- Ipsen Biopharmaceuticals, Inc.
- Pacira Pharmaceuticals, Inc.
- Acuitas Therapeutics
- LIPOSOMA B.V.
- Takeda Pharmaceutical Company Limited
- Taiwan Liposome Company, Ltd.
- Endo International
- Jazz Pharmaceuticals plc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technology
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Regulatory Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Liposome Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Liposome Drug Delivery Market, By Product, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Liposomal Paclitaxel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Liposomal Doxorubicin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Liposomal Amphotericin B
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Nasal Endoscopes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Liposome Drug Delivery Market, By Technology, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Stealth Liposome Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Non-PEGylated Liposome Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
DepoFoam Liposome Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Liposome Drug Delivery Market, By Indication, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Fungal Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cancer Therapeutics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Liposome Drug Delivery Market, By End User, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Research Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Liposome Drug Delivery Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
North Africa
Central Africa
South Africa